Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV observational study of Zhenqi Yishen Keli for chronic glomerulonephritis
ChiCTR1900021394Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Oct 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Zhenqi Fuzheng granules in chronic glomerulonephritis (CGN), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Quantitative changes of 24-hour urinary protein. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
Zhenqi Fuzheng granules
03
Conditions
chronic glomerulonephritis (CGN)
Beyond the preview
Go deeper on ChiCTR1900021394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021394.